ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
C4 Therapeutics Inc

C4 Therapeutics Inc (CCCC)

3,62
-0,01
(-0,28%)
Fermé 28 Janvier 10:00PM
3,62
-0,01
(-0,28%)
Après les heures de négociation: 12:34AM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
3,62
Prix Achat
3,62
Prix Vente
3,84
Volume échangé
2 003 670
3,5505 Fourchette du Jour 3,775
3,38 Plage de 52 semaines 11,88
Cap du marché
Clôture Veille
3,63
Ouverture
3,56
Dernière Transaction
1039268
@
3.62
(priorref)
Dernière heure de transaction
Volume financier
US$ 7 348 540
VWAP
3,6675
Volume moyen (3 m)
1 717 150
Actions en circulation
70 588 959
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,93
Bénéfice par action (BPA)
-1,88
Chiffre d'affairess
20,76M
Bénéfice net
-132,49M

À propos de C4 Therapeutics Inc

C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. C4 Therapeutics Inc is a bio-pharmaceutical company. The company is focused on harnessing the body's natural regulation of protein levels to develop novel therapeutic candidates to eliminate disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
C4 Therapeutics Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CCCC. Le dernier cours de clôture d'C4 Therapeutics était de US$3,63. Au cours de la dernière année, les actions de C4 Therapeutics ont été négociées dans une fourchette de prix de US$ 3,38 à US$ 11,88.

C4 Therapeutics compte actuellement 70 588 959 actions en circulation. La capitalisation boursière d'C4 Therapeutics est de US$256,24 million. C4 Therapeutics a un ratio cours/bénéfice (ratio PE) de -1.93.

CCCC Dernières nouvelles

C4 Therapeutics Announces 2025 Milestones Across Clinical Portfolio of Degrader Medicines Pursuing Targets of High Unmet Need in Oncology

Cemsidomide Data Presented at American Society of Hematology (ASH) Annual Meeting Support Best-in-Class Profile; Program Advancing to Next Phase of Clinical Development in Multiple Myeloma and...

C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation...

C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader

In Multiple Myeloma, Cemsidomide in Combination with Dexamethasone at Highest Dose Level Explored to Date Achieved 36 Percent Overall Response Rate (ORR) and 45 Percent Clinical Benefit Rate...

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors

Hoerter Brings Over Three Decades of Oncology Commercialization and Leadership Experience Appointment Underscores Continued Transformation of Board to Lead C4T into Next Phase of Pipeline Progress...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.29-7.41687979543.914.0253.5719877703.72902443CS
4-0.11-2.94906166223.734.263.3819733603.78444354CS
12-1.96-35.12544802875.586.523.3817171504.22728367CS
26-2.89-44.39324116746.517.35733.3812922774.9915277CS
52-1.98-35.35714285715.611.883.3816619746.33639522CS
156-18.75-83.817612874422.3726.81.0621461885.68965963CS
260-22.98-86.390977443626.651.211.0616087147.89908763CS

CCCC - Frequently Asked Questions (FAQ)

What is the current C4 Therapeutics share price?
The current share price of C4 Therapeutics is US$ 3,62
How many C4 Therapeutics shares are in issue?
C4 Therapeutics has 70 588 959 shares in issue
What is the market cap of C4 Therapeutics?
The market capitalisation of C4 Therapeutics is USD 256,24M
What is the 1 year trading range for C4 Therapeutics share price?
C4 Therapeutics has traded in the range of US$ 3,38 to US$ 11,88 during the past year
What is the PE ratio of C4 Therapeutics?
The price to earnings ratio of C4 Therapeutics is -1,93
What is the cash to sales ratio of C4 Therapeutics?
The cash to sales ratio of C4 Therapeutics is 12,35
What is the reporting currency for C4 Therapeutics?
C4 Therapeutics reports financial results in USD
What is the latest annual turnover for C4 Therapeutics?
The latest annual turnover of C4 Therapeutics is USD 20,76M
What is the latest annual profit for C4 Therapeutics?
The latest annual profit of C4 Therapeutics is USD -132,49M
What is the registered address of C4 Therapeutics?
The registered address for C4 Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the C4 Therapeutics website address?
The website address for C4 Therapeutics is www.c4therapeutics.com
Which industry sector does C4 Therapeutics operate in?
C4 Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
JGAurora Mobile Ltd
US$ 14,56
(142,18%)
38,51M
AKROAkero Therapeutics Inc
US$ 51,77
(97,75%)
15,06M
ORKTOrangeKloud Technology Inc
US$ 1,30
(88,41%)
62,83M
HWHHWH International Inc
US$ 0,49
(70,32%)
393,88M
GITSGlobal Interactive Technologies Inc
US$ 3,0424
(56,34%)
4,71M
ALLKAllakos Inc
US$ 0,2402
(-80,15%)
51,22M
NXUNXU Inc
US$ 0,2513
(-59,20%)
14,06M
VERUVeru Inc
US$ 0,6351
(-47,51%)
43,51M
WOKWORK Medical Technology Group Ltd
US$ 2,53
(-47,51%)
862,6k
NBISNebius Group NV
US$ 26,08
(-37,44%)
43,58M
NVDANVIDIA Corporation
US$ 118,42
(-16,97%)
798,94M
HWHHWH International Inc
US$ 0,49
(70,32%)
393,88M
HOLOMicroCloud Hologram Inc
US$ 1,67
(7,74%)
201,58M
ONCOOnconetix Inc
US$ 0,66
(37,50%)
185M
RGTIRigetti Computing Inc
US$ 12,44
(-5,76%)
123,5M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock